-transparent.png){kind=logo}
Betulinic acid is a pentacyclic triterpene found in many plant species, among others, in the bark of white birch Betula alba. Betulinic acid was reported to display a wide range of biological effects, including antiviral, antiparasitic, antibacterial, anticancer and anti-inflammatory activities. The effects of betulinic acid (50, 5, 0.5 mg/kg) administered orally five times at 24 hours intervals to non-immunized and red blood cells (SRBC)-immunized mice were determined. The present study examined the total number of lymphocytes in the thymus, spleen and mesenteric lymph nodes, and the percentage of subsets of T cells (CD4+CD8+, CD4CD8, CD4+, CD8+) in thymus,T (CD3+, CD4+, CD8+) and B (CD19+) lymphocytes in the spleen and mesenteric lymph nodes, as well as white blood cell (WBC) and differential leukocyte counts in non-immunized mice, and humoral immune response in SRBC-immunized mice. SRBC was injected 24 hours after administration of the last dose of betulinic acid. It was found that betulinic acid administered orally five times at the dose of 0.5 mg/kg increased the total number of thymocytes, splenocytes, lymphocytes of mesenteric lymph node cells, and the weight ratio of the spleen and mesenteric lymph nodes in non-immunized mice. Betulinic acid also changed the percentage of T cell subsets in the thymus and T and B lymphocytes in peripheral lymphatic organs. The effects of betulinic acid on T and B cell subpopulations depended on the dose applied. The strongest stimulating effect of betulinic acid was observed when the drug was administered at the dose of 0.5 mg/kg. Five exposures to betulinic acid (0.5 mg/kg) decreased the percentage of immature CD4+CD8+ thymic cells with corresponding increases in the percentage and absolute count of mature, single-positive CD4+ thymocytes and decreased the percentage and total count of CD3+ splenocytes and mesenteric lymph node cells with corresponding decreases in the percentage and absolute count of CD4+ and CD8+ cells. Multiple administration of betulinic acid at the investigated doses augmented the percentage and absolute count of CD19+ cells in the peripheral lymphatic organs. Moreover, betulinic acid at the dose of 5 mg/kg administered prior to SRBC immunization increased the number of plaque forming cells (PFC) but decreased the production of anti-SRBC antibodies on day 4 after priming. Thus, betulinic acid is a potential biological response modifier and may strengthen the immune response of its host.
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
January 2011,
Polish journal of veterinary sciences,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
January 2020,
Planta medica,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
January 2010,
Pharmacological reports : PR,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
April 2015,
Immunopharmacology and immunotoxicology,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
February 1981,
Physiology & behavior,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
April 1997,
The Journal of experimental medicine,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
February 1987,
Behavioral neuroscience,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
May 1996,
Journal of clinical epidemiology,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
January 1976,
Annales d'immunologie,
Y Jine, and
M Lis, and
M Szczypka, and
B Obmińska-Mrukowicz
November 2020,
European journal of pharmacology,
